HealthTree Logo
search more_vert
App Logo
close
person Sign In / Create Account
Learning More About Genomics and Why It Matters to African American Myeloma Patients with Dr. Gareth Morgan
Learning More About Genomics and Why It Matters to African American Myeloma Patients with Dr. Gareth Morgan image
Black Myeloma Health Community Chapter
event Nov 11, 2021 / 12:00PM - 01:00PM CST

Event Description

Dr. Gareth Morgan, an internationally recognized clinician-scientist with expertise in the field of molecular genetics and treatment of multiple myeloma, will discuss genetics/genomics and what it means for the African American community. Join us to learn more about the role your genetics plays in myeloma treatments and targeted therapy. Come with your questions.

Schedule & Agenda

person
Introduction
12:00PM
Valarie Traynham
Valarie introduces the agenda of the event and featured speaker Dr. Gareth Morgan.  
person
Presentation
12:05PM
Dr. Gareth Morgan
Dr. Gareth Morgan discusses genetics/genomics and what it means for the African American community.
person
Questions and Answers
12:35PM
Audience
Type your questions in the chat and we will answer them! 

Speakers & Moderators

The panelist Valarie Traynham
Valarie Traynham

“I became a Myeloma Coach after meeting many patients who did not have a peer mentor to ask questions and find relevant information about myeloma.”

Read Bio
The panelist Gareth Morgan, MD, PhD
Gareth Morgan, MD, PhD

Gareth Morgan, MD, PhD, is Director of Multiple Myeloma Research at NYU Langone Perlmutter Cancer Center in New York, NY. He is an internationally recognized clinician-scientist in the molecular genetics of blood cell cancers and myeloma treatment. He has a particular focus on diagnostic prevention and treatment strategies for high-risk and relapsed/refractory myeloma. Dr. Morgan is doing influential work on the characterization of the myeloma genome, defining specific subsets of the disease that have prognostic importance, and developing personalized therapeutic strategies targeted to each subtype. He is also engaged in advanced research in molecular diagnostics, drug development, and clinical trials. His research aims to cure myeloma and to reduce side effects by targeting treatment to the biology underlying each patient’s cancer. Prior to leading the Perlmutter Cancer Center’s myeloma program, Dr. Morgan was Professor of Medicine and Director of the Myeloma Institute at the University of Arkansas for Medical Sciences and Professor of Hematology and Director of the Centre for Myeloma Research at the Royal Marsden NHS Foundation Trust and The Institute of Cancer Research in London, Europe’s largest comprehensive cancer institute. He is also a founding director of the European Myeloma Network and has authored more than 500 peer-reviewed journals. Dr. Morgan received his doctorate on the genetics of leukemia from the University of London in 1991 and his bachelor of medicine in 1981 from the Welsh National School of Medicine. His post graduate medical training was completed in Wales and at the Royal Postgraduate Medical School in London.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

+1 800 709 1113

email

Support@healthtree.org

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Abbvie
Genentech
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube